Nicholson, C. David — SEC Form 4 filings
SEC reporting owner CIK 1636168. 5 Form 4 filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-06-20 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | Director | 2 | — | — | 10 |
| Adverum Biotechnologies, Inc. (ADVM) | Director | 3 | — | — | 5 |
Form 4 filings — Nicholson, C. David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/award (A): 62,800 @ $0 · Grant/award (A): 94,200 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,520 (derivative) · Disposition to issuer (D): 10,450 (derivative) | EDGAR |
| 2025-06-20 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 10,450 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Actinium Pharmaceuticals, Inc. (ATNM) | Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · +2 more | EDGAR |
| 2024-06-20 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636168 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →